LNCaP In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF942
Target Cell Organism: Human
Target Cell Name: LNCaP
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide LNCaP-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LNCaP
Target Cell Organism
Human
Target Cell Background
The LNCaP cell line was originally isolated from the lymph node of a patient with metastatic prostate cancer. Many cell lines have been derived from LNCaP by selective pressures to study different aspects of prostate cancer progression.
Related Diseases
Prostate Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
LNCaP-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry